Top Markets
#1 Black Phoenix Black Phoenix +852.80%
#2 Nesa Nesa +536.74%
#3 QuantixAI QuantixAI +103.24%
#4 MetaDAO MetaDAO +29.58%
#5 Ontology Gas Ontology Gas +23.90%
#6 Bedrock Bedrock +18.10%
#7 Stacks Stacks +13.77%
#8 peaq peaq +13.54%
#9 Humanity Humanity +13.42%
#10 Moolah Moolah +13.24%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Catalent, Inc. Catalent, Inc.

Catalent, Inc.

CTLT
Rank in Stocks #1926
Catalent, Inc., operating globally through its various subsidiaries,... Catalent, Inc., operating globally through its various subsidiaries, specializes in the development and production of comprehensive solutions for a wide array of products, including pharmaceutical drugs, protein-based biologics, advanced cell and gene therapies, and consumer health items. The company's operations are strategically divided into four key segments: Biologics; Softgel and Oral Technologies; Oral and Specialty Delivery; and Clinical Supply Services. The Softgel and Oral Technologies division focuses on the formulation, development, and manufacturing of soft capsules. These are utilized in a diverse range of client products, such as prescription medications, over-the-counter drugs, nutritional supplements, unit-dose cosmetics, and medicinal preparations for animal health. Within the Biologics segment, Catalent undertakes the creation of biologic cell lines, develops and manufactures both cell therapy and viral-based gene therapy, and handles the formulation and production of parenteral dose forms, including vials, prefilled syringes, and cartridges. This segment also provides essential analytical development and testing capabilities. The Oral and Specialty Delivery segment offers extensive formulation, development, and manufacturing expertise across various technologies. It provides integrated downstream solutions spanning clinical development and commercial supply. This segment also features a dedicated oral delivery solutions platform, encompassing preclinical screening, formulation, analytical development, and current good manufacturing practices (cGMP) services. Finally, the Clinical Supply Services segment delivers vital support for drug and biologic clinical trials. Its services include manufacturing, specialized packaging, secure storage, efficient distribution, and comprehensive inventory management. This segment also offers "FastChain," a demand-led clinical supply service. Catalent serves a broad client base, including pharmaceutical, biotechnology, and consumer health organizations, alongside companies in other healthcare sectors like animal health and medical devices, and even the cosmetics industry. The company was founded in 2007 and maintains its headquarters in Somerset, New Jersey.
Share Price
$63.48
Last synced: 2024-12-17
Market Cap
$11.52B
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Catalent, Inc. (CTLT)

Category

Healthcare
Number of shares outstanding for Catalent, Inc. (CTLT)
Number of shares outstanding as of September 2024: 182.00M
According to Catalent, Inc. latest financial reports and stock price the company's current number of shares outstanding is 182.00M. At the end of June 2023 the company had 181.00M shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Catalent, Inc. (CTLT) from 2011 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
2026 (TTM) 182.00M 0.55%
2024 181.00M 0.00%
2023 181.00M 2.84%
2022 176.00M 4.76%
2021 168.00M 12.15%
2020 149.79M 3.85%
2019 144.25M 9.94%
2018 131.20M 4.96%
2017 125.00M 0.16%
2016 124.80M 4.10%
2015 119.89M 2.20%
2014 117.30M -0.02%
2013 117.32M 0.00%
2012 117.32M 0.00%
2011 117.32M 0.00%
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 2.40B 1,218.32%
IN